Chewy, Inc. (CHWY), the largest U.S. online pet-products retailer, has seen a sharp reset in analyst expectations over recent months. After second-quarter results reported in September 2026 showed organic growth decelerating to 5.7%, several firms lowered targets or cut ratings. Evercore ISI analyst Mark Mahaney downgraded the stock to In Line with a $25 target, and J.P. Morgan moved to a Hold-equivalent rating with a $24 target, citing muted organic growth and macro pressure.
Reviewed together, the individual, current analyst targets form a broad band. The arithmetic mean of the verified targets examined comes to roughly $28.38, which rounds to a $28 central target. The low-to-high range runs from approximately $21 to $36, with Morgan Stanley at the top end ($36) and several Hold-rated firms clustered near $24. This wide dispersion signals that the average analyst price target is not a forecast but a midpoint across genuinely divided opinions about Chewy's ability to re-accelerate growth.
Chewy last closed near $21.93, down roughly 39% over the trailing 52 weeks. Reaching $28 would require a gain of about 28%, a substantial move that sits well above the stock's recent trading range but below its earlier 52-week highs. In fiscal Q2 2026, net sales rose 7.3% year over year to $3.33 billion, while active customers grew 3.8% to 21.7 million and net sales per active customer reached $602. Autoship orders represented 84.6% of net sales, underscoring a highly recurring revenue base. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) margin reached 6.8%. The company raised its full-year sales outlook, but the slower organic pace and a forward price-to-earnings (P/E) ratio near 13 to 14 show investors are weighing durability against valuation.
The stock has traded within a broad 52-week range, with a recent low near $17.40 and an earlier high around $37. The $21–$22 area has acted as a consolidation zone after the post-earnings decline, while $28 sits near a prior area of analyst-target clustering and represents a meaningful resistance level above current prices. A sustained move toward $28 would likely require clearing overhead supply accumulated during the stock's multi-month downtrend.
Most analyst price targets reflect a research horizon of roughly 12 months, though firms differ in their assumptions and timing. Investors should watch the next quarterly earnings report (expected around December 2026), guidance updates, and any revisions from the firms that recently downgraded the name. Other items to monitor include active-customer and Autoship trends, Chewy Health clinic economics, margin trajectory, AI cost-savings progress, and any changes in BC Partners' ownership stake.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use the tool to discover opportunities, keep an eye on positions, and identify shifting trends more efficiently than manual scanning. For those following CHWY or the broader market, this resource offers a data-driven way to complement traditional research.
Can CHWY reach $28? The $28 central target represents the arithmetic mean of verified analyst targets spanning roughly $21 to $36, requiring about a 28% advance from the latest price near $21.93. Support could come from recurring revenue, margin improvement, and health-care and AI initiatives, while decelerating organic growth, consumer softness, recent downgrades, and the BC Partners overhang are the principal obstacles. The unusually wide analyst range shows how uncertain the growth path remains. Whether the stock approaches $28 will likely depend on stabilization in organic growth and credible new catalysts, not on the target itself.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, CHWY has been loosely correlated with CVNA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CHWY jumps, then CVNA could also see price increases.
| Ticker / NAME | Correlation To CHWY | 1D Price Change % | ||
|---|---|---|---|---|
| CHWY | 100% | -2.38% | ||
| CVNA - CHWY | 53% Loosely correlated | -4.10% | ||
| ETSY - CHWY | 35% Loosely correlated | -0.07% | ||
| W - CHWY | 30% Poorly correlated | -2.58% | ||
| VIPS - CHWY | 29% Poorly correlated | -1.75% | ||
| RVLV - CHWY | 28% Poorly correlated | -5.78% | ||
More | ||||